THANK YOU FOR SUBSCRIBING


Joe E. Kiani CEO & Chairman of the Board, MasimoFounded in 1989, Masimo is committed to improve patient outcomes and reduce cost of care. “We achieve this by partnering with patient monitoring companies and caregivers and creating innovative, cost-effective acquisition programs for Masimo SET products for the benefit of the patients,” states Kiani.
The company’s measure-through motion and low perfusion pulse oximetry, Masimo SET (Signal Extraction Technology) outperforms other pulse oximetry technologies, under the most challenging clinical conditions. “In addition, SET pulse oximetry provides perfusion index (PI) and pleth variability index (PVI) which increases the ability to detect life-threatening events and reduce false alarms during challenging conditions.”
![]()
Our non invasive technology is revolutionizing patient monitoring, including Masimo SET pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous monitoring technology
Company
Masimo
Management
Joe E. Kiani CEO & Chairman of the Board, Masimo
Description
Develops and manufactures innovative noninvasive
patient monitoring technologies, including medical
devices and a wide array of sensors